ACCL1931 - A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy
Details
Age
All Ages
Locations
Childrens Hospital Colorado
Principal Investigator
Lisa Hartman
Study ID
Protocol Number: 23-2165
More information available at ClinicalTrials.gov: NCT05501899
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers